Results 321 to 330 of about 17,175,483 (375)
The Evolution of Functional Amyloids and Their Impact on Host–Microbe Interactions
This review describes functional amyloids and highlights the importance of structural repetition and molecular mimicry that distinguish the amyloid fold. The authors describe how amyloid can be the last universal common ancestor of protein folds. The authors also discuss how microbes utilize functional amyloids and how the structural characteristics of
Divya Kolli +3 more
wiley +1 more source
Genome Sequencing Uncovers Additional Findings in Phelan‐McDermid Syndrome
ABSTRACT Phelan‐McDermid syndrome (PMS) is a genetic condition caused by deletions of chromosome 22q13.3 or pathogenic variants in the SHANK3 gene. Neurologic features typically include intellectual disability, autism spectrum disorder, hypotonia, and absent speech, though there is considerable variability even among individuals with the same molecular
Rachel Gore Moses +21 more
wiley +1 more source
Febrile neutropenia in patients with Duffy-null-associated neutrophil counts and multiple myeloma or AL amyloidosis. [PDF]
Abdallah M +13 more
europepmc +1 more source
SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?
European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Flavio Tangianu +3 more
wiley +1 more source
Abstract INTRODUCTION Obesity is a major modifiable risk factor for Alzheimer's disease (AD), but the mechanistic link between peripheral metabolic dysfunction and AD progression remains unclear. Adipose‐derived extracellular vesicles (EVs) may penetrate the brain and alter lipid homeostasis, contributing to neurodegeneration.
Li Yang +10 more
wiley +1 more source
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. [PDF]
Morgan GJ +4 more
europepmc +1 more source
White matter hyperintensities precede other biomarkers in GRN frontotemporal dementia
Abstract INTRODUCTION Increased white matter hyperintensities (WMHs) have been reported in genetic frontotemporal dementia (FTD) in small studies, but the sequence of WMH abnormalities relative to other biomarkers is unclear. METHODS Using a large dataset (n = 763 GENFI2 participants), we measured WMHs and examined them across genetic FTD variants and ...
Mahdie Soltaninejad +38 more
wiley +1 more source
Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized by amyloid‐beta (Aβ) deposition and tau pathology. Although disease‐modifying therapies, such as anti‐Aβ monoclonal antibodies, have been approved, their clinical efficacy remains modest and accompanied by substantial safety concerns. The glymphatic system, which is a brain‐
Jiangwei Ding +3 more
wiley +1 more source
Spontaneous Hepatic Hemorrhage as a Rare Presentation of Amyloid Light Chain (AL) Amyloidosis: A Case Report. [PDF]
Srivastava M.
europepmc +1 more source
Abstract INTRODUCTION Despite having few vascular risk factors, people with Down syndrome (DS) have MRI evidence of cerebrovascular disease (CVD) and neuroinflammation that worsens with Alzheimer's disease (AD) severity. We investigated whether markers of CVD and inflammation are associated with AD‐related diagnostic progression in people with DS ...
Natalie C. Edwards +25 more
wiley +1 more source

